| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 345.23B | 240.19B | 179.20B | 147.96B | 101.61B |
| Gross Profit | 57.30B | 38.20B | 27.42B | 20.90B | 17.41B |
| EBITDA | 15.64B | 11.02B | 5.23B | 3.90B | 4.30B |
| Net Income | 16.85B | 16.63B | 5.31B | 5.26B | 4.85B |
Balance Sheet | |||||
| Total Assets | 290.53B | 229.39B | 192.60B | 157.83B | 134.34B |
| Cash, Cash Equivalents and Short-Term Investments | 68.25B | 40.87B | 35.75B | 33.34B | 28.01B |
| Total Debt | 23.12B | 6.51B | 8.10B | 13.16B | 4.51B |
| Total Liabilities | 196.88B | 136.97B | 107.45B | 81.63B | 64.12B |
| Stockholders Equity | 92.44B | 86.74B | 80.51B | 75.13B | 68.61B |
Cash Flow | |||||
| Free Cash Flow | 42.71B | 23.47B | 7.02B | 5.68B | 9.25B |
| Operating Cash Flow | 46.73B | 26.51B | 22.34B | 16.02B | 15.35B |
| Investing Cash Flow | -24.45B | -9.13B | -16.14B | -12.13B | -7.16B |
| Financing Cash Flow | -1.42B | -13.30B | -2.76B | 1.33B | 916.02M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | HK$201.66B | 9.88 | 18.03% | 1.95% | 39.48% | -27.45% | |
71 Outperform | HK$151.02B | 6.92 | 41.37% | ― | ― | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$151.03B | 16.53 | 10.49% | 3.41% | 17.13% | -18.63% | |
58 Neutral | HK$811.45B | 29.17 | 11.86% | 1.55% | -3.19% | -40.56% | |
50 Neutral | HK$98.40B | -37.76 | -7.56% | ― | 50.00% | 54.46% | |
48 Neutral | HK$104.78B | -50.70 | -2.49% | ― | -23.28% | -123.34% |